Mieszala M, Jennings H, Drab M, Gamian A
Arch Immunol Ther Exp (Warsz). 2019; 67(4):237-248.
PMID: 31030218
PMC: 6597602.
DOI: 10.1007/s00005-019-00542-9.
Paoletti L, Kasper D
Microbiol Spectr. 2019; 7(2).
PMID: 30873933
PMC: 11590616.
DOI: 10.1128/microbiolspec.GPP3-0001-2017.
Berti F, Campisi E, Toniolo C, Morelli L, Crotti S, Rosini R
J Biol Chem. 2014; 289(34):23437-48.
PMID: 24990951
PMC: 4156066.
DOI: 10.1074/jbc.M114.567974.
Maisey H, Doran K, Nizet V
Expert Rev Mol Med. 2008; 10:e27.
PMID: 18803886
PMC: 2676346.
DOI: 10.1017/S1462399408000811.
Aoyagi Y, Adderson E, Rubens C, Bohnsack J, Min J, Matsushita M
Infect Immun. 2007; 76(1):179-88.
PMID: 17938215
PMC: 2223634.
DOI: 10.1128/IAI.00837-07.
Reevaluating the serotype II capsular locus of Streptococcus agalactiae.
Martins E, Melo-Cristino J, Ramirez M
J Clin Microbiol. 2007; 45(10):3384-6.
PMID: 17715372
PMC: 2045322.
DOI: 10.1128/JCM.01296-07.
Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.
Carlin A, Lewis A, Varki A, Nizet V
J Bacteriol. 2006; 189(4):1231-7.
PMID: 16997964
PMC: 1797352.
DOI: 10.1128/JB.01155-06.
Structural and genetic diversity of group B streptococcus capsular polysaccharides.
Cieslewicz M, Chaffin D, Glusman G, Kasper D, Madan A, Rodrigues S
Infect Immun. 2005; 73(5):3096-103.
PMID: 15845517
PMC: 1087335.
DOI: 10.1128/IAI.73.5.3096-3103.2005.
Discovery and characterization of sialic acid O-acetylation in group B Streptococcus.
Lewis A, Nizet V, Varki A
Proc Natl Acad Sci U S A. 2004; 101(30):11123-8.
PMID: 15263085
PMC: 503750.
DOI: 10.1073/pnas.0403010101.
Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.
Albanyan E, Edwards M
Infect Immun. 2000; 68(10):5794-802.
PMID: 10992487
PMC: 101539.
DOI: 10.1128/IAI.68.10.5794-5802.2000.
The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon.
Chaffin D, Beres S, Yim H, Rubens C
J Bacteriol. 2000; 182(16):4466-77.
PMID: 10913080
PMC: 94618.
DOI: 10.1128/JB.182.16.4466-4477.2000.
Regulation of cell component production by growth rate in the group B Streptococcus.
Ross R, Madoff L, Paoletti L
J Bacteriol. 1999; 181(17):5389-94.
PMID: 10464211
PMC: 94046.
DOI: 10.1128/JB.181.17.5389-5394.1999.
Ozonolysis for selectively depolymerizing polysaccharides containing beta-D-aldosidic linkages.
Wang Y, Hollingsworth R, Kasper D
Proc Natl Acad Sci U S A. 1998; 95(12):6584-9.
PMID: 9618455
PMC: 22569.
DOI: 10.1073/pnas.95.12.6584.
Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide.
Paoletti L, Ross R, Johnson K
Infect Immun. 1996; 64(4):1220-6.
PMID: 8606082
PMC: 173907.
DOI: 10.1128/iai.64.4.1220-1226.1996.
Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).
von Hunolstein C, DAscenzi S, Wagner B, Jelinkova J, Alfarone G, Recchia S
Infect Immun. 1993; 61(4):1272-80.
PMID: 8454331
PMC: 281358.
DOI: 10.1128/iai.61.4.1272-1280.1993.
Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine.
Paoletti L, Wessels M, Rodewald A, Shroff A, Jennings H, Kasper D
Infect Immun. 1994; 62(8):3236-43.
PMID: 8039893
PMC: 302951.
DOI: 10.1128/iai.62.8.3236-3243.1994.
Immunochemical analysis and immunogenicity of the type II group B streptococcal capsular polysaccharide.
Kasper D, Baker C, Galdes B, Katzenellenbogen E, Jennings H
J Clin Invest. 1983; 72(1):260-9.
PMID: 6192144
PMC: 1129181.
DOI: 10.1172/jci110965.
Isolation, chemical composition, and molecular size of extracellular type II and type Ia polysaccharides of group B streptococci.
De Cueninck B, Greber T, Eisenstein T, Swenson R, SHOCKMAN G
Infect Immun. 1983; 41(2):527-34.
PMID: 6192084
PMC: 264673.
DOI: 10.1128/iai.41.2.527-534.1983.
Typing of Streptococcus agalactiae (Lancefield group B).
Colman G
Eur J Clin Microbiol Infect Dis. 1988; 7(2):226-31.
PMID: 3134226
DOI: 10.1007/BF01963093.
Seroepidemiology of group B Streptococcus type II antibody specificity.
Gray B, Pritchard D, Springfield J, Benak R, DILLON Jr H
Epidemiol Infect. 1988; 101(2):347-54.
PMID: 3053221
PMC: 2249364.
DOI: 10.1017/s0950268800054285.
